Chapter

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

Steven M. Teutsch, Linda A. Bradley, Glenn E. Palomaki, James E. Haddow, Margaret Piper, Ned Calonge, W. David Dotson, Michael P. Douglas and Alfred O. Berg

in Human Genome Epidemiology, 2nd Edition

Published in print December 2009 | ISBN: 9780195398441
Published online May 2010 | e-ISBN: 9780199776023 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195398441.003.0023
 							The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Preview

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative, established by the Office of Public Health Genomics at the Centers for Disease Control and Prevention, supports the development and implementation of a rigorous, evidence-based process for evaluating genetic tests, and other genomic applications for clinical and public health practice in the United States. An independent, nonfederal EGAPP Working Group (EWG), a multidisciplinary expert panel, selects topics, oversees the systematic review of evidence, and makes recommendations based on that evidence. This chapter describes the EGAPP processes, and details the specific methods and approaches used by the EWG.

Keywords: EGAPP; EGAPP Working Group; genomics

Chapter.  10406 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.